Chinese molecular diagnostics company GenomePrecision Technology has concluded its Series B funding.
GenomePrecision landed $15 million in funding round.
The round was conducted by Yizhuang Biomedical M&A Fund.
With the net funds, the company will advance its molecular diagnostics technology products including medical tests.